Martin Christopher Nathan

Martin Christopher Nathan is listed in filings as Director at Oruka Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 11, 2025, including 2 public disclosures. Recent filings connect the profile to Oruka Therapeutics, Inc. (ORKA) and Edgewise Therapeutics, Inc. (EWTX). The current snapshot covers public activity from Nov 24, 2025 to Dec 11, 2025. Reported amounts are shown as $1.1M to $1.0M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.